Zhejiang Total Other Income Expense Net from 2010 to 2025

002099 Stock   4.95  0.12  2.37%   
Zhejiang Hisoar's Total Other Income Expense Net is increasing over the years with stable fluctuation. Overall, Total Other Income Expense Net is expected to go to about 50.3 M this year. From 2010 to 2025 Zhejiang Hisoar Total Other Income Expense Net quarterly data regression line had arithmetic mean of  15,909,225 and r-squared of  0.06. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
2010-12-31
Previous Quarter
47.9 M
Current Value
50.3 M
Quarterly Volatility
53.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zhejiang Hisoar financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zhejiang Hisoar's main balance sheet or income statement drivers, such as Interest Expense of 45.6 M, Net Income Applicable To Common Shares of 201.2 M or Selling General Administrative of 161.1 M, as well as many indicators such as . Zhejiang financial statements analysis is a perfect complement when working with Zhejiang Hisoar Valuation or Volatility modules.
  
This module can also supplement various Zhejiang Hisoar Technical models . Check out the analysis of Zhejiang Hisoar Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Zhejiang Stock

Zhejiang Hisoar financial ratios help investors to determine whether Zhejiang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhejiang with respect to the benefits of owning Zhejiang Hisoar security.